Walgreens introduced it’s partnering with Pearl Well being, which gives a expertise platform for major care practices in value-based care preparations, to increase value-based care choices in collaboration with major care suppliers.
Pearl Well being gives a expertise platform for major care suppliers collaborating in Medicare’s ACO REACH mannequin. The platform contains information visualizations and proposals that permit clinicians to see which sufferers may have additional assist, akin to these with a number of persistent circumstances or these just lately discharged from a hospital.
The startup’s instruments intention to distill affected person info into easy-to-digest stories and observe metrics like readmission charges and whether or not sufferers attend annual wellness visits.
Via the partnership, Walgreens will present complementary prescription achievement, immunizations, treatment adherence, diagnostic testing and care-gap closure. The pharmacy chain will even work with healthcare suppliers to help sufferers discharged from the hospital transition to house.
“At Pearl Well being, we imagine that native major care suppliers are key to enhancing America’s general well being. Our technology-powered value-based care mannequin aligns seamlessly with the healthcare companies Walgreens gives, notably in essentially the most susceptible communities,” Michael Kopko, chief government officer of Pearl Well being, mentioned in a press release.
“With a deal with proactive, coordinated care, we’ll collaborate to ship a greater resolution to suppliers and in the end ship high-quality companies to sufferers whereas managing their care effectively. We’re very excited concerning the implications of this partnership for sufferers in Medicare and past.”
THE LARGER TREND
In January, Pearl Well being raised $75 million in Sequence B funding. The corporate introduced an $18 million Sequence A in September 2021.
Different firms offering assist and expertise companies to practices in value-based care preparations embrace UpStream Healthcare, which raised $140 million in Sequence B funding, and Aledade, which scooped up $123 million in a Sequence E spherical final 12 months.
